Table 1 Maternal and neonatal characteristics for breast milk samples analyzed according to the 4 groups
Mean ± SD, No. (%) | |||||
|---|---|---|---|---|---|
PL-Low | PL-High | S-DHA-Low | S-DHA-High | P -value 1 | |
Mothers | (n = 10) | (n = 10) | (n = 10) | (n = 10) | |
Pre pregnancy | |||||
Weight, mean (SD) 2, kg | 62.78 ± 17.38 | 69.59 ± 15.32 | 76.27 ± 12.88 | 64.53 ± 11.90 | 0.16 |
Body Mass Index, mean2 (SD), kg/m2 | 23.83 ± 6.70 | 26.91 ± 5.64 | 27.75 ± 5.05 | 23.23 ± 5.00 | 0.17 |
Before delivery | |||||
Receive corticosteroids, % | |||||
Yes | 90.0 | 100 | 100 | 70.0 | 0.17 |
No | 10.0 | 0.0 | 0.0 | 30.0 | |
At delivery | |||||
Age, mean (SD), y | 29.20 ± 5.43 | 33.10 ± 5.07 | 31.10 ± 3.84 | 33.40 ± 4.45 | 0.22 |
Delivery Mode, % | |||||
Vaginal | 60.0 | 40.0 | 50.0 | 20.0 | 0.39 |
Cesarean | 40.0 | 60.0 | 50.0 | 80.0 | |
Parity, mean (SD) | 1.70 ± 1.16 | 1.20 ± 1.23 | 1.10 ± 1.20 | 0.80 ± 0.63 | 0.27 |
Maternal dietary DHA intake, mean, mg/d | 51.9 ± 76.4 | 196.7 ± 282.1 | 132.7 ± 212.5 | 146.7 ± 146.8 | 0.24 |
Preeclampsia Eclampsia, % | |||||
Yes | 10.0 | 20.0 | 10.0 | 10.0 | 1.00 |
No | 90.0 | 80.0 | 90.0 | 90.0 | |
At 14 days after delivery | |||||
Compliance, % | 71 ± 23 | 88 ± 21 | 47 ± 38 | 99 ± 4 | 0.002 |
Infants | |||||
Neonatal Sex | |||||
Male | 60.0 | 80.0 | 80.0 | 60.0 | 0.67 |
Female | 40.0 | 20.0 | 20.0 | 40.0 | |
Gestational age, wk | 25.8 ± 1.6 | 26.6 ± 1.6 | 27.2 ± 1.0 | 25.8 ± 1.4 | 0.12 |
Birth weight, g | 842.8 222.8 | 896.7 205.4 | 987.5 260.6 | 755.9 228.1 | 0.20 |